© 1997 American Heart Association, Inc.
Articles |
Topographical Association Between the Cyclin-Dependent Kinases Inhibitor P21, p53 Accumulation, and Cellular Proliferation in Human Atherosclerotic Tissue
From the Departments of Pathology (C.I., G.M., E.W., H.E.S.) and Medical Biometrics and Informatics (J.S.M.), University of Freiburg; and the Department of Internal Medicine IV, University of Frankfurt (A.M.Z.), Germany.
Correspondence to Christian Ihling, MD, Department of Pathology, University of Freiburg, Albertstraße 19, D-79104 Freiburg.
Abstract The cell cycle is controlled by
cyclin-dependent protein kinases (CDKs). The activity of these enzymes
is directed by inhibitors of CDKs. The 21-kD protein
product (P21) of the WAF1/CIP1 gene, which can be
transactivated by the protein product of the tumor
suppressor gene p53, acts as an inhibitor of
cyclin-dependent kinases. To assess whether both P21 and p53 may play a
role in the control of cellular proliferation in atherosclerotic
lesions, the topographical association between p53, P21, and the
proliferation marker MIB1/Ki-67, was analyzed by
immunohistochemistry in human carotid atheromatous
plaques of 26 patients. p53 immunoreactivity (IR) was present in 26
of 26 cases in the nuclei of virtually all cell types
(macrophages [MPs], smooth muscle cells [SMCs],
endothelial cells [ECs]) in areas with chronic
inflammation in 71.08±8.28% of the nuclei. p53 staining in the
control tissue from human coronary arteries was present in
0.3±0.45% of the cells (P<.002). P21-IR was present
in 24 of 26 specimens in 64.38±10.13% of the cells (controls:
3.8±1.85%, P<.002) and localized to nuclei of MPs (CD68
positive) and SMCs (
-actin positive), as well as ECs of microvessels
present in 21 specimens (21 of 21) and luminal ECs present in
18 specimens (16 of 18). As shown by double labeling, P21-IR
colocalized with p53-IR in most MPs (24 of 24), intimal SMCs (22 of
24), ECs of microvessels (19 of 21), and luminal ECs (10 of 16).
Interestingly, few p53-positive cells did not show
simultaneous P21-IR, and, conversely, not all P21-positive
cells demonstrated p53-IR. MIB1/Ki-67-positive cells were identified in
21 of 26 tissue specimens in 3.53±1.79% of the nuclei (controls: 0%,
P<.002) and localized principally to MPs bordering the
atheromatous lipid core (21 of 26) and to a few
scattered SMCs (16 of 26), ECs of microvessels (13 of 21), and luminal
ECs (2 of 18). Most importantly, none of the cells coexpressing P21 and
p53 were positive for MIB1/Ki-67-IR, indicating the absence of
proliferating activity. In summary, this study demonstrates that P21-IR
is present in the atherosclerotic plaque and colocalizes with p53
in most MPs, SMCs, and ECs. The lack of proliferation markers in cells
coexpressing p53 and P21 suggests that transcriptional activation of
the WAF1/CIP1 gene by p53 may be involved in the control of
cellular proliferation in advanced human atherosclerotic plaques.
Key Words: cell proliferation • p53 • atherosclerosis • P21 • WAF1/CIP1 gene
This article has been cited by other articles:
 |
|
 |
|
  S. M. Sanz-Gonzalez, L. Barquin, I. Garcia-Cao, M. Roque, J. M. Gonzalez, J. J. Fuster, M. T. Castells, J. M. Flores, M. Serrano, and V. Andres Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis Cardiovasc Res, September 1, 2007; 75(4): 803 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Minamino and I. Komuro Vascular Cell Senescence: Contribution to Atherosclerosis Circ. Res., January 5, 2007; 100(1): 15 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Gorenne, M. Kavurma, S. Scott, and M. Bennett Vascular smooth muscle cell senescence in atherosclerosis Cardiovasc Res, October 1, 2006; 72(1): 9 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kunieda, T. Minamino, J.-i. Nishi, K. Tateno, T. Oyama, T. Katsuno, H. Miyauchi, M. Orimo, S. Okada, M. Takamura, et al. Angiotensin II Induces Premature Senescence of Vascular Smooth Muscle Cells and Accelerates the Development of Atherosclerosis via a p21-Dependent Pathway Circulation, August 29, 2006; 114(9): 953 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chen and M. S. Goligorsky Premature senescence of endothelial cells: Methusaleh's dilemma Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1729 - H1739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mercer, N. Figg, V. Stoneman, D. Braganza, and M. R. Bennett Endogenous p53 Protects Vascular Smooth Muscle Cells From Apoptosis and Reduces Atherosclerosis in ApoE Knockout Mice Circ. Res., April 1, 2005; 96(6): 667 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Andres Unexpected Proatherogenic Properties of p21: Beyond Cell Cycle Control? Circulation, December 21, 2004; 110(25): 3749 - 3752. [Full Text] [PDF]
|
|
|
|
|
|
M. L. Rossi, N. Marziliano, P. A. Merlini, E. Bramucci, U. Canosi, G. Belli, D. Z. Parenti, P. M. Mannucci, and D. Ardissino Different Quantitative Apoptotic Traits in Coronary Atherosclerotic Plaques From Patients With Stable Angina Pectoris and Acute Coronary Syndromes Circulation, September 28, 2004; 110(13): 1767 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Andres Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential Cardiovasc Res, July 1, 2004; 63(1): 11 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Zettler, M. A. Prociuk, J. A. Austria, G. Zhong, and G. N. Pierce Oxidized Low-Density Lipoprotein Retards the Growth of Proliferating Cells by Inhibiting Nuclear Translocation of Cell Cycle Proteins Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 727 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Khanna Concerted effect of transforming growth factor-{beta}, cyclin inhibitor p21, and c-myc on smooth muscle cell proliferation Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1133 - H1140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O'Sullivan, S. D Scott, N. McCarthy, N. Figg, L. M Shapiro, P. Kirkpatrick, and M. R Bennett Differential cyclin E expression in human in-stent stenosis smooth muscle cells identifies targets for selective anti-restenosis therapy Cardiovasc Res, December 1, 2003; 60(3): 673 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Diez-Juan and V. Andres Coordinate Control of Proliferation and Migration by the p27Kip1/Cyclin-Dependent Kinase/Retinoblastoma Pathway in Vascular Smooth Muscle Cells and Fibroblasts Circ. Res., March 7, 2003; 92(4): 402 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Martinet, D. M. Schrijvers, G. R.Y. De Meyer, J. Thielemans, M. W.M. Knaapen, A. G. Herman, and M. M. Kockx Gene Expression Profiling of Apoptosis-Related Genes in Human Atherosclerosis: Upregulation of Death-Associated Protein Kinase Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 2023 - 2029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Fanzo, S. K. Reaves, L. Cui, L. Zhu, and K. Y. Lei p53 protein and p21 mRNA levels and caspase-3 activity are altered by zinc status in aortic endothelial cells Am J Physiol Cell Physiol, August 1, 2002; 283(2): C631 - C638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Imdahl, G. Bognar, J. Schulte-Monting, U. Schoffel, E.H. Farthmann, and C. Ihling Predictive factors for response to neoadjuvant therapy in patients with oesophageal cancer Eur. J. Cardiothorac. Surg., April 1, 2002; 21(4): 657 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Scott, M. O'Sullivan, S. Hafizi, L. M. Shapiro, and M. R. Bennett Human Vascular Smooth Muscle Cells From Restenosis or In-Stent Stenosis Sites Demonstrate Enhanced Responses to p53: Implications for Brachytherapy and Drug Treatment for Restenosis Circ. Res., March 8, 2002; 90(4): 398 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Mayr, M. Mayr, C. Li, F. Wernig, H. Dietrich, Y. Hu, and Q. Xu Loss of p53 Accelerates Neointimal Lesions of Vein Bypass Grafts in Mice Circ. Res., February 8, 2002; 90(2): 197 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Tabas p53 and Atherosclerosis Circ. Res., April 27, 2001; 88(8): 747 - 749. [Full Text] [PDF]
|
|
|
|
|
|
T.-S. Lee and L.-Y. Chau Fas/Fas ligand-mediated death pathway is involved in oxLDL-induced apoptosis in vascular smooth muscle cells Am J Physiol Cell Physiol, March 1, 2001; 280(3): C709 - C718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rodriguez-Campos, P. Ruiz-Enriquez, S. Faraudo, and L. Badimon Mitogen-Induced p53 Downregulation Precedes Vascular Smooth Muscle Cell Migration From Healthy Tunica Media and Proliferation Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 214 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Khanna and J. D. Hosenpud In Vitro and In Vivo Transfection of p21 Gene Enhances Cyclosporin A-Mediated Inhibition of Lymphocyte Proliferation J. Immunol., August 15, 2000; 165(4): 1882 - 1888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Metzler, Y. Hu, H. Dietrich, and Q. Xu Increased Expression and Activation of Stress-Activated Protein Kinases/c-Jun NH2-Terminal Protein Kinases in Atherosclerotic Lesions Coincide with p53 Am. J. Pathol., June 1, 2000; 156(6): 1875 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M Kockx and A. G Herman Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res, February 1, 2000; 45(3): 736 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. McCarthy and M. Bennett The regulation of vascular smooth muscle cell apoptosis Cardiovasc Res, February 1, 2000; 45(3): 747 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tan, Y. Wang, K. Guan, and Y. Sun PTGF-beta , a type beta transforming growth factor (TGF-beta ) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway PNAS, January 4, 2000; 97(1): 109 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fukumoto, H. Koyama, M. Hosoi, K. Yamakawa, S. Tanaka, H. Morii, and Y. Nishizawa Distinct Role of cAMP and cGMP in the Cell Cycle Control of Vascular Smooth Muscle Cells : cGMP Delays Cell Cycle Transition Through Suppression of Cyclin D1 and Cyclin-Dependent Kinase 4 Activation Circ. Res., November 26, 1999; 85(11): 985 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Ihling, T Szombathy, K Nampoothiri, J Haendeler, F Beyersdorf, M Uhl, A M Zeiher, and H E Schaefer Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation Heart, September 1, 1999; 82(3): 286 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Kockx Apoptosis in the Atherosclerotic Plaque : Quantitative and Qualitative Aspects Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1519 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Mayr, M. Mayr, C. Li, F. Wernig, H. Dietrich, Y. Hu, and Q. Xu Loss of p53 Accelerates Neointimal Lesions of Vein Bypass Grafts in Mice Circ. Res., February 8, 2002; 90(2): 197 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Scott, M. O'Sullivan, S. Hafizi, L. M. Shapiro, and M. R. Bennett Human Vascular Smooth Muscle Cells From Restenosis or In-Stent Stenosis Sites Demonstrate Enhanced Responses to p53: Implications for Brachytherapy and Drug Treatment for Restenosis Circ. Res., March 8, 2002; 90(4): 398 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J.M. van Vlijmen, G. Gerritsen, A. L. Franken, L. S.M. Boesten, M. M. Kockx, M. J. Gijbels, M. P. Vierboom, M. van Eck, B. van de Water, T. J.C. van Berkel, et al. Macrophage p53 Deficiency Leads to Enhanced Atherosclerosis in APOE*3-Leiden Transgenic Mice Circ. Res., April 27, 2001; 88(8): 780 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. von der Thusen, B. J.M. van Vlijmen, R. C. Hoeben, M. M. Kockx, L.M. Havekes, T. J.C. van Berkel, and E. A.L. Biessen Induction of Atherosclerotic Plaque Rupture in Apolipoprotein E-/- Mice After Adenovirus-Mediated Transfer of p53 Circulation, April 30, 2002; 105(17): 2064 - 2070. [Abstract] [Full Text] [PDF]
|
|